|
2025-04-04 |
2025-04-02 |
S
Sale
|
Tactic Pharma LLC
Chief Executive Officer
Executive Director
Large shareholder
|
33,334
-3.9%
35.00
USD 1,166,690
|
33,334
-3.9%
|
35.00
|
USD 1,166,690
|
|
|
2024-10-30 |
2024-10-28 |
B
Purchase
|
Radhakrishnan Karthik
Chief Financial Officer
Officer
|
1,550
+inf%
16.25
USD 25,188
|
1,550
+inf%
|
16.25
|
USD 25,188
|
|
|
2024-06-21 |
2024-06-20 |
B
Purchase
|
Cittadine Andrew
Chief Operating Officer
Officer
|
20,508
+12.4%
0.74
USD 15,254
|
20,508
+12.4%
|
0.74
|
USD 15,254
|
|
|
2024-06-21 |
2024-06-18 |
B
Purchase
|
Cittadine Andrew
Chief Operating Officer
Officer
|
12,000
+7.8%
0.86
USD 10,320
|
12,000
+7.8%
|
0.86
|
USD 10,320
|
|
|
2024-06-17 |
2024-06-17 |
B
Purchase
|
Cittadine Andrew
Chief Operating Officer
Officer
|
12,000
+8.5%
0.90
USD 10,799
|
12,000
+8.5%
|
0.90
|
USD 10,799
|
|
|
2024-06-17 |
2024-06-14 |
B
Purchase
|
Cittadine Andrew
Chief Operating Officer
Officer
|
12,000
+9.3%
0.93
USD 11,176
|
12,000
+9.3%
|
0.93
|
USD 11,176
|
|
|
2024-06-17 |
2024-06-13 |
B
Purchase
|
Cittadine Andrew
Chief Operating Officer
Officer
|
12,000
+10.2%
0.91
USD 10,920
|
12,000
+10.2%
|
0.91
|
USD 10,920
|
|
|
2024-06-05 |
2024-06-04 |
B
Purchase
|
Cittadine Andrew
Chief Operating Officer
Officer
|
12,000
+11.4%
0.78
USD 9,360
|
12,000
+11.4%
|
0.78
|
USD 9,360
|
|
|
2024-06-05 |
2024-06-03 |
B
Purchase
|
Cittadine Andrew
Chief Operating Officer
Officer
|
12,000
+12.8%
0.76
USD 9,120
|
12,000
+12.8%
|
0.76
|
USD 9,120
|
|
|
2024-05-31 |
2024-05-31 |
B
Purchase
|
Cittadine Andrew
Chief Operating Officer
Officer
|
12,000
+14.7%
0.64
USD 7,732
|
12,000
+14.7%
|
0.64
|
USD 7,732
|
|
|
2024-05-31 |
2024-05-30 |
B
Purchase
|
Cittadine Andrew
Chief Operating Officer
Officer
|
12,000
+17.2%
0.64
USD 7,676
|
12,000
+17.2%
|
0.64
|
USD 7,676
|
|
|
2024-05-31 |
2024-05-29 |
B
Purchase
|
Cittadine Andrew
Chief Operating Officer
Officer
|
12,000
+20.8%
0.64
USD 7,643
|
12,000
+20.8%
|
0.64
|
USD 7,643
|
|
|
2022-11-16 |
2022-11-15 |
B
Purchase
|
Cittadine Andrew
Chief Operating Officer
Officer
|
10,000
+70.2%
3.15
USD 31,500
|
10,000
+70.2%
|
3.15
|
USD 31,500
|
|
|
2022-11-16 |
2022-11-14 |
B
Purchase
|
Cittadine Andrew
Chief Operating Officer
Officer
|
6,053
+74.0%
3.00
USD 18,159
|
6,053
+74.0%
|
3.00
|
USD 18,159
|
|
|
2021-02-16 |
2021-02-11 |
PS
Planned sale
|
Tactic Pharma LLC
Chief Scientific Officer
Large shareholder
|
11,929
-6.7%
16.90
USD 201,600
|
11,929
-6.7%
|
16.90
|
USD 201,600
|
|
|
2021-02-16 |
2021-02-11 |
PS
Planned sale
|
Tactic Pharma LLC
Chief Scientific Officer
Large shareholder
|
16,384
-8.4%
16.44
USD 269,353
|
16,384
-8.4%
|
16.44
|
USD 269,353
|
|
|
2021-02-16 |
2021-02-11 |
PS
Planned sale
|
Tactic Pharma LLC
Chief Scientific Officer
Large shareholder
|
29,996
-13.3%
15.12
USD 453,540
|
29,996
-13.3%
|
15.12
|
USD 453,540
|
|
|
2021-02-16 |
2021-02-11 |
PS
Planned sale
|
Tactic Pharma LLC
Chief Scientific Officer
Large shareholder
|
24,224
-9.7%
14.09
USD 341,316
|
24,224
-9.7%
|
14.09
|
USD 341,316
|
|
|
2021-02-16 |
2021-02-11 |
PS
Planned sale
|
Tactic Pharma LLC
Chief Scientific Officer
Large shareholder
|
42,467
-14.6%
13.30
USD 564,811
|
42,467
-14.6%
|
13.30
|
USD 564,811
|
|
|
2019-12-20 |
2019-12-18 |
B
Purchase
|
Tsuchimoto Kim R
Chief Financial Officer
|
325
+inf%
8.00
USD 2,600
|
325
+inf%
|
8.00
|
USD 2,600
|
|
|
2019-12-20 |
2019-12-18 |
B
Purchase
|
Tactic Pharma LLC
Chief Scientific Officer
|
125,000
+75.0%
8.00
USD 1,000,000
|
125,000
+75.0%
|
8.00
|
USD 1,000,000
|
|
|
2019-12-20 |
2019-12-18 |
B
Purchase
|
Hendricks Diane
|
468,750
+inf%
8.00
USD 3,750,000
|
468,750
+inf%
|
8.00
|
USD 3,750,000
|
|
|
2019-12-20 |
2019-12-18 |
B
Purchase
|
Leo Karl
|
314
+inf%
8.00
USD 2,510
|
314
+inf%
|
8.00
|
USD 2,510
|
|
|
2019-12-20 |
2019-12-18 |
B
Purchase
|
Leo Karl
|
156,250
+inf%
8.00
USD 1,250,000
|
156,250
+inf%
|
8.00
|
USD 1,250,000
|
|
